AU3178200A - Genetic analysis - Google Patents

Genetic analysis

Info

Publication number
AU3178200A
AU3178200A AU31782/00A AU3178200A AU3178200A AU 3178200 A AU3178200 A AU 3178200A AU 31782/00 A AU31782/00 A AU 31782/00A AU 3178200 A AU3178200 A AU 3178200A AU 3178200 A AU3178200 A AU 3178200A
Authority
AU
Australia
Prior art keywords
genetic analysis
genetic
analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31782/00A
Inventor
Luis Martin-Parras
Michael Alan Reeve
Nicholas Ian Workman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Original Assignee
Amersham Pharmacia Biotech UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Pharmacia Biotech UK Ltd filed Critical Amersham Pharmacia Biotech UK Ltd
Publication of AU3178200A publication Critical patent/AU3178200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
AU31782/00A 1999-03-12 2000-03-10 Genetic analysis Abandoned AU3178200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99301933 1999-03-12
EP99301933 1999-03-12
PCT/GB2000/000916 WO2000055364A2 (en) 1999-03-12 2000-03-10 Genetic analysis

Publications (1)

Publication Number Publication Date
AU3178200A true AU3178200A (en) 2000-10-04

Family

ID=8241266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31782/00A Abandoned AU3178200A (en) 1999-03-12 2000-03-10 Genetic analysis

Country Status (5)

Country Link
EP (1) EP1173609A2 (en)
JP (1) JP2002538837A (en)
AU (1) AU3178200A (en)
CA (1) CA2362771A1 (en)
WO (1) WO2000055364A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141371B2 (en) 2002-09-06 2006-11-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for detecting and localizing DNA mutations by microarray
DE602006019855D1 (en) 2005-05-10 2011-03-10 Oregon State METHOD OF MAPPING POLYMORPHISMS AND POLYMORPHISM MICROARRAYS
GB2487341A (en) * 2009-11-02 2012-07-18 Nugen Technologies Inc Compositions and methods for targeted nucleic acid sequence selection and amplification
EP2769007B1 (en) 2011-10-19 2016-12-07 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
WO2013112923A1 (en) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
WO2013191775A2 (en) 2012-06-18 2013-12-27 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US20140274738A1 (en) 2013-03-15 2014-09-18 Nugen Technologies, Inc. Sequential sequencing
CA2929596C (en) 2013-11-13 2022-07-05 Nugen Technologies, Inc. Compositions and methods for identification of a duplicate sequencing read
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
WO2016022833A1 (en) 2014-08-06 2016-02-11 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0226288A3 (en) * 1985-10-09 1989-06-28 Collaborative Research Inc. Means and method of testing for cystic fibrosis based on genetic linkage
US4771384A (en) * 1986-07-24 1988-09-13 Dnastar, Inc. System and method for fragmentation mapping
WO1989001526A1 (en) * 1987-08-07 1989-02-23 Genelabs Incorporated Coincidence cloning method and library
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5316908A (en) * 1990-07-13 1994-05-31 Life Technologies, Inc. Size markers for electrophoretic analysis of DNA
AU3728093A (en) * 1992-02-19 1993-09-13 Public Health Research Institute Of The City Of New York, Inc., The Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
US5750335A (en) * 1992-04-24 1998-05-12 Massachusetts Institute Of Technology Screening for genetic variation
US5376526A (en) * 1992-05-06 1994-12-27 The Board Of Trustees Of The Leland Stanford Junior University Genomic mismatch scanning
US5436142A (en) * 1992-11-12 1995-07-25 Cold Spring Harbor Laboratory Methods for producing probes capable of distingushing variant genomic sequences
DK0725821T3 (en) * 1993-10-28 1999-02-15 Life Technologies Inc Nucleic acid marker ladder for mass estimation
US5710000A (en) * 1994-09-16 1998-01-20 Affymetrix, Inc. Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping
AU2264197A (en) * 1996-02-09 1997-08-28 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Restriction display (rd-pcr) of differentially expressed mrnas

Also Published As

Publication number Publication date
EP1173609A2 (en) 2002-01-23
WO2000055364A3 (en) 2001-10-11
JP2002538837A (en) 2002-11-19
WO2000055364A2 (en) 2000-09-21
CA2362771A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU3678100A (en) Biosensor
AU1173201A (en) Skin-gripper
AU2925600A (en) Genetic screening
AU4975300A (en) Dna melting curve analysis
AU6045900A (en) Interaction-activated proteins
AU7933000A (en) Material analysis
AU3178200A (en) Genetic analysis
AU2308900A (en) Analysis method
AU6387000A (en) Serial analysis of genetic alterations
AUPQ262599A0 (en) Gene expression
AU2023701A (en) Sketcher
AU4568900A (en) Improved can
EP1144631A3 (en) Insulin-synthesis genes
AU6859500A (en) Plant gene
AU4387300A (en) Beehive
AU2001284265A1 (en) Genetic study
AU6925800A (en) Autogrid analysis
AU6382000A (en) Genome analysis
AU1901801A (en) Glucofuranoses
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU3444300A (en) Genetic analysis
AU5049001A (en) Dna analysis
AU4808200A (en) Dna balls
AU1915601A (en) Periotome

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase